Rigel Announces Fourth Quarter and Year End 2017 Financial Results and Provides Company Update

Go back to Rigel Announces Fourth Quarter and Year End 2017 Financial Results and Provides Company Update
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) Delayed: 35.73 +2.82 (8.57%)
Previous Close $32.91    52 Week High $4.38 
Open $33.65    52 Week Low $1.88 
Day High $36.53    P/E N/A 
Day Low $33.64    EPS $-1.12 
Volume 600,121